Switch to:

Biomarin Pharmaceutical Gross Profit

: $1,264 Mil (TTM As of Sep. 2019)
View and export this data going back to 1999. Start your Free Trial

Biomarin Pharmaceutical's gross profit for the three months ended in Sep. 2019 was $364 Mil. Biomarin Pharmaceutical's gross profit for the trailing twelve months (TTM) ended in Sep. 2019 was $1,264 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Biomarin Pharmaceutical's gross profit for the three months ended in Sep. 2019 was $364 Mil. Biomarin Pharmaceutical's Revenue for the three months ended in Sep. 2019 was $461 Mil. Therefore, Biomarin Pharmaceutical's Gross Margin % for the quarter that ended in Sep. 2019 was 78.97%.

Biomarin Pharmaceutical had a gross margin of 78.97% for the quarter that ended in Sep. 2019 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Biomarin Pharmaceutical was 83.88%. The lowest was 78.86%. And the median was 81.46%.

Warning Sign:

Biomarin Pharmaceutical Inc gross margin has been in long term decline. The average rate of decline per year is -1.2%.


Biomarin Pharmaceutical Gross Profit Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Biomarin Pharmaceutical Annual Data
Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18
Gross Profit Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 627.02 737.89 907.23 1,071.86 1,175.95

Biomarin Pharmaceutical Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Gross Profit Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 312.81 278.20 311.56 310.33 364.15

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Biomarin Pharmaceutical Gross Profit Distribution

* The bar in red indicates where Biomarin Pharmaceutical's Gross Profit falls into.



Biomarin Pharmaceutical Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Biomarin Pharmaceutical's Gross Profit for the fiscal year that ended in Dec. 2018 is calculated as

Gross Profit (A: Dec. 2018 )=Revenue - Cost of Goods Sold
=1491.212 - 315.264
=1,176

Biomarin Pharmaceutical's Gross Profit for the quarter that ended in Sep. 2019 is calculated as

Gross Profit (Q: Sep. 2019 )=Revenue - Cost of Goods Sold
=461.097 - 96.949
=364

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2019 was 278.195 (Dec. 2018 ) + 311.563 (Mar. 2019 ) + 310.327 (Jun. 2019 ) + 364.148 (Sep. 2019 ) = $1,264 Mil.

Gross Profit is the numerator in the calculation of Gross Margin:

Biomarin Pharmaceutical's Gross Margin % for the quarter that ended in Sep. 2019 is calculated as

Gross Margin % (Q: Sep. 2019 )=Gross Profit (Q: Sep. 2019 ) / Revenue (Q: Sep. 2019 )
=(Revenue - Cost of Goods Sold) / Revenue
=364 / 461.097
=78.97 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Biomarin Pharmaceutical  (NAS:BMRN) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Biomarin Pharmaceutical had a gross margin of 78.97% for the quarter that ended in Sep. 2019 => Durable competitive advantage


Biomarin Pharmaceutical Gross Profit Related Terms


Biomarin Pharmaceutical Gross Profit Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
/* */